CAS: 1268863-35-9
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | 2-(4-fluorophenyl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid REF: IN-DA01EE83CAS: 1268863-35-9 | 98% | 103,00 €~239,00 € | Sex 22 Nov 24 |
 | BioE-1115 REF: 3D-TAC86335CAS: 1268863-35-9 | Min. 95% | A consultar | Sex 03 Jan 25 |
 | BioE-1115 REF: TM-T10547CAS: 1268863-35-9 | 97.38% | A consultar | Sex 10 Jan 25 |
 | 2-(4-Fluorophenyl)-3-(isopropyl(methyl)amino)quinoxaline-6-carboxylic acid REF: 10-F547704CAS: 1268863-35-9 | 98.0% | - - - | Produto descontinuado |
![2-(4-fluorophenyl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid](https://static.cymitquimica.com/products/IN/thumb/DA01EE83.jpg)
2-(4-fluorophenyl)-3-[methyl(propan-2-yl)amino]quinoxaline-6-carboxylic acid
CAS:1268863-35-9
Fórmula:
C19H18FN3O2
Pureza:
98%
Peso molecular:
339.3635
Ref: IN-DA01EE83
| 5mg | 103,00 € | ||
| 10mg | 113,00 € | ||
| 25mg | 152,00 € | ||
| 50mg | 198,00 € | ||
| 100mg | 239,00 € |
Entrega estimada em Estados Unidos, Sexta-feira 22 de Novembro de 2024
BioE-1115
CAS:1268863-35-9
BioE-1115 is a glucagon-like peptide-1 (GLP-1) analogue that has been shown to bind to the …
Fórmula:
C19H18FN3O2
Pureza:
Min. 95%
Peso molecular:
339.4 g/mol
Ref: 3D-TAC86335
| 5mg | 246,00 € | ||
| 50mg | 980,00 € |
Entrega estimada em Estados Unidos, Sexta-feira 3 de Janeiro de 2025
BioE-1115
CAS:1268863-35-9
BioE-1115 is a selective and potent inhibitor of serine-threonine protein kinase (PASK, IC50 = 4 …
Fórmula:
C19H18FN3O2
Pureza:
97.38%
Cor e Forma:
Solid
Peso molecular:
339.36
Ref: TM-T10547
| 5mg | 35,00 € | ||
| 10mg | 46,00 € | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 1mL*10mM (DMSO) | 36,00 € |
Entrega estimada em Estados Unidos, Sexta-feira 10 de Janeiro de 2025
2-(4-Fluorophenyl)-3-(isopropyl(methyl)amino)quinoxaline-6-carboxylic acid
CAS:1268863-35-9
Pureza:
98.0%
Peso molecular:
339.3699951171875
Ref: 10-F547704
| 1g | Descontinuado | Solicitar informações | |
| 250mg | Descontinuado | Solicitar informações |
